BrandLaunchX World Premiere
Your biotech or pharma launch deserves the same precision as your science.
“When the science succeeds, the launch must too.”
Join us for the public launch of BrandLaunchX — a 45-minute live session that will show you how predictive launch intelligence can de-risk your commercial execution, accelerate your time to market, and maximise the value of your therapeutic’s pivotal moment.
Reserve your placeSee what is coming before it costs you.
Over 80% of therapeutic launches underperform expectation. The issue is rarely the therapy — it is the orchestration. Learn how predictive intelligence can surface emerging risks weeks before they materialise, giving your team time to act rather than react.
Compress time to market without losing control.
Every week of unnecessary delay is a week of lost revenue, competitive exposure, and delayed patient access. See how intelligent launch navigation keeps critical paths moving, aligns cross-functional teams, and removes the coordination drag that siloed execution creates.
Protect the full value of your launch window.
A single day of launch delay can cost up to $16M. The patent revenue window is finite. Discover how better orchestration protects capital efficiency, first-wave sales performance, and the geographic reach that determines whether your therapy gets to the patients who need it.
Practical answers to the questions
launch teams are already carrying.
This is not a product pitch. It is a 45-minute session built around the real pressures facing commercial leaders in mid-tier biotech and pharma — and a clear demonstration of what becomes possible when launch execution keeps pace with the science behind it.
Why most launches underperform — and what the actual cause is
An independent expert perspective on the structural gap between therapeutic development and commercial execution, and what it costs in revenue, access, and investor confidence.
What a 31% to 89% on-time launch probability improvement looks like in practice
A live demonstration of BrandLaunchX against a realistic biotech launch scenario — focused on outcomes and strategic decisions, not interface features.
How launch efficiency creates headroom for broader patient access
The commercial and human outcomes are connected. See how time-to-market gains and cost efficiencies translate directly into expanded geographic reach and earlier patient access.
Your questions answered by the full leadership team
The session closes with a live Q&A panel. Commercial, product, technology, and strategy leads are all present to address what matters to you directly.
45 focused minutes.
Four connected acts.
The session opens with an independent keynote from Eugene Prokopchuk — a former GSK finance director who has spent over 15 years evaluating and governing AI and digital investment inside global life sciences organisations. He will make the evidence-based case for why this category of intelligent launch orchestration is needed now.
Abhijit Sengupta, Founder and CEO of BrandLaunchX, will then take you through a live demonstration of the platform — not as a feature tour, but as a strategic walkthrough built around a realistic launch scenario and the three outcomes it is designed to deliver.
The session closes with an open Q&A with the full leadership team. Ask what you need to ask.
People who have lived
this problem from both sides.
This session is led by practitioners, not presenters.
Abhijit Sengupta
Founder and CEO, BrandLaunchX
Former AstraZeneca and Novartis Executive
Abhi brings over two decades of life sciences commercial leadership to BrandLaunchX. He built the platform from a deep conviction that commercial execution should never be the reason a therapy fails to reach the patients it was designed to help — and that with the right intelligence layer, it does not have to be.
Eugene Prokopchuk
CFA | EMBA · Former GSK Global Commercial
Digital and Tech Finance Director
Eugene Prokopchuk is a commercial finance leader with 15+ years’ experience in biotech and healthcare, including senior roles at GSK. He specializes in value creation across product launches, market prioritization, omnichannel investment and capital allocation, helping biotech innovators build commercially credible strategies and investor-ready growth narratives.
We would love
to see you there.
Places are kept deliberately small to make sure the session is focused and the Q&A is genuinely useful. Complete the short form and we will be in touch to confirm your place, along with your personal Zoom link and a diary reminder ahead of the event.
- 1 Complete the short registration form — it takes under a minute.
- 2 We will send you a confirmation email with your personal Zoom link and a calendar invitation.
- 3 Join us on Tuesday 12 May at 4:00pm UK / 11:00am EDT / 8:00am PDT.
BrandLaunchX is a trading name of ConformanceX Ltd. By registering you consent to being contacted by the BrandLaunchX team regarding this event and related communications. We will not share your details with third parties.